Wildfire smoke study aims to uncover hidden lung risks
NCT ID NCT07536178
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will expose 24 healthy adults to different levels of wildfire smoke in a safe, controlled room to see how it affects their lungs and brain. Researchers want to understand why some people may be more vulnerable to long-term lung diseases like asthma, COPD, and lung cancer. The goal is to find early warning signs of damage before disease develops.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Woodsmoke (Lodgepole Pine) exposure
- What this could lead to
- If successful, this could help identify biological markers that predict who is at risk for chronic lung diseases from wildfire smoke.
- What could go wrong
- This is a very small, early-stage study (24 people) that only looks at short-term effects in a controlled lab, not real-world repeated exposure. It may not translate to long-term health outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple CT scan catch lung cancer earlier in kuwait?
- Can tracking severe asthma over time unlock better treatments?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Seeing the fight: new imaging tracer may reveal how immune cells attack lung cancer
- Can pressurized breathing boost mucus clearance in lung disease?
- Your Tumor's DNA might predict immunotherapy success